De Barsy syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2962OMIM:219150Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

De Barsy syndrome (also known as De Barsy-Moens-Dierckx syndrome or progeroid syndrome of De Barsy) is an extremely rare autosomal recessive disorder characterized by a distinctive combination of cutis laxa (loose, wrinkled, inelastic skin), a progeroid (prematurely aged) appearance, corneal clouding, and intellectual disability. The condition is caused by mutations in the PYCR1 gene (or in some cases the ALDH18A1 gene), which are involved in proline metabolism, a process essential for connective tissue integrity. The syndrome is typically apparent at birth or in early infancy. The disease affects multiple body systems. Skin manifestations include generalized cutis laxa giving a wrinkled, aged appearance even in infancy. Ophthalmologic features include corneal opacities or corneal clouding and sometimes cataracts. Neurological involvement includes intellectual disability of variable severity, hypotonia, and in some cases movement abnormalities such as athetosis. Skeletal abnormalities may include short stature, joint hypermobility, and osteoporosis. Affected individuals may also have intrauterine growth restriction and postnatal growth retardation. Facial features are often described as distinctive, with a large fontanelle, prominent forehead, and small face with a thin nose. There is currently no cure or specific treatment for De Barsy syndrome. Management is supportive and multidisciplinary, focusing on addressing individual symptoms. This may include ophthalmologic interventions for corneal clouding, physical therapy for hypotonia and motor delays, developmental support for intellectual disability, and dermatologic care. Regular monitoring by specialists in genetics, ophthalmology, neurology, and orthopedics is recommended. Life expectancy and long-term prognosis vary depending on the severity of organ involvement.

Also known as:

Clinical phenotype terms— hover any for plain English:

Premature rupture of membranesHP:0001788Talipes calcaneovalgusHP:0001884AthetosisHP:0002305Generalized joint hypermobilityHP:0002761Decreased muscle massHP:0003199Prominent nasolabial foldHP:0005272Progeroid facial appearanceHP:0005328Recurrent sinopulmonary infectionsHP:0005425Prominent veins on trunkHP:0007457
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for De Barsy syndrome.

View clinical trials →

No actively recruiting trials found for De Barsy syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the De Barsy syndrome community →

No specialists are currently listed for De Barsy syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to De Barsy syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open De Barsy syndromeForum →

No community posts yet. Be the first to share your experience with De Barsy syndrome.

Start the conversation →

Latest news about De Barsy syndrome

No recent news articles for De Barsy syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about De Barsy syndrome

What is De Barsy syndrome?

De Barsy syndrome (also known as De Barsy-Moens-Dierckx syndrome or progeroid syndrome of De Barsy) is an extremely rare autosomal recessive disorder characterized by a distinctive combination of cutis laxa (loose, wrinkled, inelastic skin), a progeroid (prematurely aged) appearance, corneal clouding, and intellectual disability. The condition is caused by mutations in the PYCR1 gene (or in some cases the ALDH18A1 gene), which are involved in proline metabolism, a process essential for connective tissue integrity. The syndrome is typically apparent at birth or in early infancy. The disease af

How is De Barsy syndrome inherited?

De Barsy syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does De Barsy syndrome typically begin?

Typical onset of De Barsy syndrome is neonatal. Age of onset can vary across affected individuals.